alphablocker antihypertensive
Name
alphablocker_n
Label
Alpha-Blocker: Number taken verified by inspection
Units
medications
Type
numeric
Visit number vs Alpha-Blocker: Number taken verified by inspection
N Mean StdDev Median Min Max Unknown Total
Baseline 318 0.03 ± 0.2 0.0 0.0 1.0 - 318
Follow-up 300 0.03 ± 0.2 0.0 0.0 1.0 1 301
Treatment Arm vs Alpha-Blocker: Number taken verified by inspection
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 318 0.03 ± 0.2 0.0 0.0 1.0 - 318
Healthy Lifestyles and Sleep Education - control arm (HLSE) 106 0.03 ± 0.2 0.0 0.0 1.0 - 106
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 106 0.06 ± 0.2 0.0 0.0 1.0 - 106
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 106 0.0 ± 0.0 0.0 0.0 0.0 - 106
Treatment Arm vs Alpha-Blocker: Number taken verified by inspection
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 300 0.03 ± 0.2 0.0 0.0 1.0 1 301
Healthy Lifestyles and Sleep Education - control arm (HLSE) 100 0.03 ± 0.2 0.0 0.0 1.0 - 100
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 101 0.06 ± 0.2 0.0 0.0 1.0 - 101
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 99 0.01 ± 0.1 0.0 0.0 1.0 1 100
Age category vs Alpha-Blocker: Number taken verified by inspection
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 318 0.03 ± 0.2 0.0 0.0 1.0 - 318
45-54 years 53 0.02 ± 0.1 0.0 0.0 1.0 - 53
55-64 years 139 0.03 ± 0.2 0.0 0.0 1.0 - 139
65 years or older 126 0.03 ± 0.2 0.0 0.0 1.0 - 126
Age category vs Alpha-Blocker: Number taken verified by inspection
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 300 0.03 ± 0.2 0.0 0.0 1.0 - 300
45-54 years 49 0.02 ± 0.1 0.0 0.0 1.0 - 49
55-64 years 127 0.03 ± 0.2 0.0 0.0 1.0 - 127
65 years or older 124 0.04 ± 0.2 0.0 0.0 1.0 - 124
Gender of the participant vs Alpha-Blocker: Number taken verified by inspection
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 318 0.03 ± 0.2 0.0 0.0 1.0 - 318
Female 84 0.0 ± 0.0 0.0 0.0 0.0 - 84
Male 234 0.04 ± 0.2 0.0 0.0 1.0 - 234
Gender of the participant vs Alpha-Blocker: Number taken verified by inspection
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 300 0.03 ± 0.2 0.0 0.0 1.0 1 301
Female 79 0.0 ± 0.0 0.0 0.0 0.0 - 79
Male 221 0.05 ± 0.2 0.0 0.0 1.0 1 222
Race of the participant vs Alpha-Blocker: Number taken verified by inspection
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 317 0.03 ± 0.2 0.0 0.0 1.0 - 317
White 256 0.02 ± 0.2 0.0 0.0 1.0 - 256
American Indian or Alaskan Native 2 0.0 ± 0.0 0.0 0.0 0.0 - 2
Black or African American 43 0.05 ± 0.2 0.0 0.0 1.0 - 43
Asian 6 0.0 ± 0.0 0.0 0.0 0.0 - 6
Native Hawaiian or other Pacific islander 1 0.0 - 0.0 0.0 0.0 - 1
Other 4 0.0 ± 0.0 0.0 0.0 0.0 - 4
Multiple 5 0.2 ± 0.4 0.0 0.0 1.0 - 5
Race of the participant vs Alpha-Blocker: Number taken verified by inspection
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 299 0.03 ± 0.2 0.0 0.0 1.0 - 299
White 241 0.03 ± 0.2 0.0 0.0 1.0 - 241
American Indian or Alaskan Native 2 0.0 ± 0.0 0.0 0.0 0.0 - 2
Black or African American 41 0.05 ± 0.2 0.0 0.0 1.0 - 41
Asian 6 0.0 ± 0.0 0.0 0.0 0.0 - 6
Native Hawaiian or other Pacific islander 1 0.0 - 0.0 0.0 0.0 - 1
Other 3 0.0 ± 0.0 0.0 0.0 0.0 - 3
Multiple 5 0.2 ± 0.4 0.0 0.0 1.0 - 5